It revealed that the dysmenorrhea group exhibited a younger age of onset (29.95 ± 5.39 vs. 31.58 ± 6.09 years, p = 0.006), higher CA125 levels (128.6 ± 102.4 vs. 45.2 ± 38.7 U/mL, p = 0.001), and higher rASRM scores (78.5 ± 25.1 vs. 42.3 ± 18.9, p = 0.001), along with a higher incidence of deep infiltrating nodules (DINs) and infertility, aligning with findings from previous studies (6–12). The gene discussed is MUC16; the disease is Dysmenorrhea.